BIO.News Newsletter

It can all feel a little overwhelming right now—but thanks to science, there's hope. Today we have insights on what biotech is doing to tackle the health and climate crises and ensure our industry is more collaborative and inclusive, even when this is all over. Here are around 840 words, just over 4 minutes.

There are two things you must do this fall: get ready to vote and get a flu vaccine. More details below, including the outlook for drug pricing policy and why the flu shot is even more important during a pandemic, in around 870 words, 4 and a half minutes. P.S. Join us today at 1:00 PM ET for the first in four-part webinar series on biotech IP. Sponsored by Choate Hall & Stewart LLP, To Pool, Pledge, or License: Allocating IP Rights During COVID-19 R&D will feature different perspectives from…

A lot of breaking news this weekend, including the drug pricing executive order yesterday. We have the details, plus an announcement from a member working on innovative animal biotech, in around 890 words, 4 and a half minutes.

It’s the 19th anniversary of 9/11; here’s a look at what the memorial ceremonies will be like this year. Today, we have discussions on One Health from unexpected sources, a quick explainer on phase 3 clinical trials, and a look at a busy Friday in Washington, in around 950 words, just under 4 minutes.

Yesterday was a big news day. Here’s what you need to know about vaccine trial safety, plus a big announcement about a headline speaker at BIO IMPACT Digital, in about 640 words, 3 minutes.

Big news today from biopharmaceutical companies about what they’re doing to ensure the public's trust in the safety and efficacy of a future COVID-19 vaccine, plus insights on why we should study bats to help us understand the virus. Here are about 750 words, just under 4 minutes.

Washington’s officially back to work. To kick off the short but sure-to-be-busy week, we take a closer look at Twist Bioscience’s antibody announcement as well as a recent meeting with South Africa’s biotech industry and regulators. Here are around 900 words, 4 and a half minutes.

Before you log off for the holiday weekend, we have the scoop on a new rule that will help ensure patients have access to the latest transformative therapies, as well as a look at how biotech is improving your last summer cookout of the season. Here are 790 words, just under 4 minutes.  Good Day BIO is taking a quick break for Labor Day. We’ll be in touch if there’s major breaking news, but otherwise, we’ll resume regular publication on Tuesday, September 8.

Congrats to BIO members Horizon Therapeutics and AbbVie for being named among PEOPLE Magazine’s 50 Companies That Care, recognizing companies that have gone “above and beyond" for employees during the pandemic. We’re proud to work with you, and so many others, who care about their employees, patients, and the planet. Today, we have news on how the biotech industry is working to build public trust in new medical developments and EPA’s proposed rule that would help modernize plant biotech…

Breaking news! We’re launching a new initiative to help you register to vote and get the information you need to make an informed decision on November 3—no matter which way you lean politically. Details, plus a lot of news links from Washington, in around 670 words, 3 minutes, 20 seconds.